Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that John W. Smither, who served as Arcutis’...
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study...
Increase the number of employees to guide the direction of the company and promote the growth strategy as a next-generation CDMO.
To continue its momentum...
Over 2,500m2 expansion for Adeno-Associated and Lentiviral Vector development and manufacturing built for large-scale and Late-Phase Clinical and Commercial Demands.
AGC Biologics, a leading global...
Eli Lilly and Company and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the...
